8 completed. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 1 | Completed 1 |
Follow MoviPrep: new trials by email Literature Review of MoviPrep trials Research Report on MoviPrep
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep® Phase II: NTC015 low dose, Phase II: NTC015 medium dose, Phase II: NTC015 high dose - Elective Colonoscopy | Phase 2 / Phase 3 | Completed | NTC srl | 886 | 2020-06-18 | 2025-12-08 |
| Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy CDFR0612, CDFR0613, Coolprep Powder - Colonoscopy Preparation, Colon Disease | Phase 3 | Completed | CTC Bio, Inc. | 310 | 2015-01-01 | 2015-09-11 |
| Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients PEG-ascorbate 2L, PEG 4L - Diabetes Mellitus, Colonic Diseases | Phase 3 | Completed | Parc de Salut Mar | 158 | 2014-12-02 | 2017-02-23 |
| Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. NER1006, 2-Day Split-Dosing, NER1006,1-Day Morning Split-Dosing, MOVIPREP, 2-Day Split-Dosing - Colorectal Cancer, Colorectal Carcinoma | Phase 3 | Completed | Norgine | 849 | 2014-10-01 | 2018-05-15 |
| Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation MOVIPREP - Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel. | Phase 3 | Completed | Takeda | 140 | 2012-11-01 | 2014-05-15 |
| Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Macrogol 3350 Na sulphate NaCl KCl Ascorbic Acid Na Ascorbate, Sodium Phosphate solution (NaP) - Colonoscopy | Phase 3 | Completed | Norgine | 360 | 2004-09-01 | 2008-04-16 |
| A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate, Macrogol3350 Na sulphate Na bicarbonate NaCl KCl - Colonoscopy | Phase 3 | Completed | Norgine | 360 | 2002-06-01 | 2008-04-16 |
| MOVIPREP® Versus NaP Pivotal Phase III Study macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate, Sodium Phosphate Solution - Colonoscopy | Phase 3 | Completed | Norgine | 340 | 2002-04-01 | 2008-04-16 |
Colonic Diseases (2) · Colorectal Neoplasms (1) · Diabetes Mellitus (1) · Mucopolysaccharidosis IV (1) · Personal Satisfaction (1)
Norgine (4) · CTC Bio, Inc. (1) · NTC srl (1) · Parc de Salut Mar (1) · Takeda (1)
Germany (4) · France (3) · Italy (2) · Russia (2) · Spain (2) · Belgium (1) · Kazakhstan (1) · Poland (1) · South Korea (1) · United Kingdom (1)
Christian Ell, Prof Dr med (2) · Alain Bitoun, MD (1) · Dongjin Yoo, M.D. (1) · Gianpiero Manes, Dr. (1) · Raf Bisschops, MD (1)
PMID 18190651, PMID 25180609, PMID 30025414, PMID 36064325, PMID 36799346, PMID 40786127
2019 (1)